MAM
PRAX icon

Meeder Asset Management’s Praxis Precision Medicines PRAX Stock Holding History

Meeder Asset Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.34K Sell
7
-9
-56% -$2.85K ﹤0.01% 909
2026
Q1 		$5.16K Buy
+16
New +$4.95K ﹤0.01% 814

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Meeder Asset Management's PRAX Position: Q2 2026 in Review

Meeder Asset Management reduced its Praxis Precision Medicines (PRAX) stake by 56% in Q2 2026, selling an estimated $2.85K and leaving 7 shares worth $2.34K. The position accounts for ﹤0.01% of the portfolio, ranked #909.

Meeder Asset Management first reported a position in PRAX in Q1 2026 and has held it in 2 quarters since. The position peaked at $5.16K in Q1 2026. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Meeder Asset Management held 7 shares of Praxis Precision Medicines worth $2.34K as of Q2 2026.
  • Meeder Asset Management sold 9 Praxis Precision Medicines shares in Q2 2026, an estimated $2.85K.
  • Praxis Precision Medicines made up ﹤0.01% of Meeder Asset Management's portfolio in Q2 2026, its #909 holding.
  • Meeder Asset Management first reported a position in Praxis Precision Medicines in Q1 2026 and has held it in 2 quarters since.
  • Meeder Asset Management's Praxis Precision Medicines position peaked at $5.16K in Q1 2026.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Meeder Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.